Indolocarbazole anticancer agents and methods of using same

Details Indolocarbazole anticancer agents and methods of using same Indolocarbazole anticancer agents and methods of using same

2006-10-17

2006-10-17

Lewis, Patrick (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S025000, C536S017400, C536S017700, C536S018700

Reexamination Certificate

active

07122526

ABSTRACT:
The present invention relates to anti-tumor compounds, compositions and methods. In particular, the invention relates to indolocarbazole analogues of the following general formulas that inhibit topoisomerase I activity

REFERENCES:
patent: 5106742 (1992-04-01), Wall et al.
patent: 5401747 (1995-03-01), Wall et al.
patent: 5437996 (1995-08-01), Kojiri et al.
patent: 5559235 (1996-09-01), Luzzio et al.
patent: 5589365 (1996-12-01), Kojiri et al.
patent: 5591842 (1997-01-01), Kojiri et al.
patent: 5643760 (1997-07-01), Kojiri et al.
patent: 5668271 (1997-09-01), Kojiri et al.
patent: 5804564 (1998-09-01), Kojiri et al.
patent: 5859261 (1999-01-01), Faul et al.
patent: 5883114 (1999-03-01), Kleinschroth et al.
patent: 5922860 (1999-07-01), Kojiri et al.
patent: WO 96/04293 (1996-02-01), None
patent: WO 97/09339 (1997-03-01), None
Anizon, et al., “Syntheses and Biological Activities (Topoisomerase Inhibition and Antitumor and Antimicrobial Properties) of Rebeccamycin Analogues Bearing Modified Sugar Moieties and Substituted on the Imide Nitrogen with a Methyl Group,”J. Med. Chem, vol. 40, 1997, pp. 3456-3465.
Pereira, et al., “Structure-Activity Relationship in a Series of Substituted Indolocarbazoles: Topoisomerase I and Protein Kinase C inhibition and Antitumoral and Antimicrobial Properties,”J. Med. Chem. vol. 39, 1996, pp. 4471-4477.
Yamashita, et al., “Induction of Mammalian DNA Topoisomerase I Mediated DNA Cleavage by Antitumor Indolocarbazole Derivatives,”Biochemistry1992, vol. 31, pp. 12069-12075.
Zembower, et al., “Indolocarbazole Poisons of Human Topoisomerase I: Regioisomeric Analogues of ED-110”Bioorganic & Medicinal Chemistry Letters 9, 1999, pp.145-150.
Arakawa, et al, “Novel Indolocarbazole Compound 6-N-Formylamino-12, 13-dihydro-1,11-dihydroxy-13-(β-D-glucopyranosyl)-5-H-indolo[2,3-a]pyrrolo-[3,4-c] carbazole-5,7 (6H)-dione (NB-506): It's Potent Antitumor Activities in Mice”,Cancer Research., vol. 55, p. 1316-1320, 1995.
Arakawa, et al., “ED-110, a Novel Indolcarbazole, Prevents the Growth of Experimental Tumors in Mice”,Japan. Journal Cancer Res., 84, p. 574-581, May 1993.
Batcho et al., “Indoles from 2-Methylinitorbenzenes by Condensation with formamide Acetals Followed by Reduction: 4-Benzyloxyindole”,Organic Syntheses. Collective Volumes III, p. 34-41, 1990.
Champoux, “Mechanism of Catalysis by Eukaryotic DNA Topoisomerase I”,Adv. Pharmacol., 29A, p. 71-82, 1994.
Kaneko, et al., “Two Synthetic Approaches to Rebeccamycin”,Tetrahedron Letters, vol. 16, No. 34, p. 4015-4018, 1985.
Ohkubo, et al., “Synthesis of Dissymmetric Indolocarbazole Glycosides Using the Mitsunobu Reaction at the Glycosylation Step”,Tetrahedron, vol. 53, No. 17, p. 5937-5950, 1997.
Pommier, et al., “Mechanisms of Topoisomerase I Inhibition by Anticancer Drugs”,Advances in Pharmacology, vol. 29B, p. 73-92, 1994.
Redinbo, et al., “Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNA”,Science, vol. 279, p. 1504-1513, 1998.
Yoshinari, et al., “Mode of Action of a New Indolocarbazole Anticancer Agent, J-107088, Targeting Topoisomerase I”Cancer Research, vol. 59, p. 4271-4275, 1999.
Bailley et al., “DNA Cleavage by Topoisomerase I in the Presence of Indolocarbazole Derivatives of Rebeccamycin,”Biochemistry, vol. 36, 1997, pp. 3917-3929.
Bailley et al., “Enhanced Binding to DNA and Topoisomerase I Inhibition by an Analog of the Antitumor Antibiotic Rebecamycin Containing an Amino Sugar Residue,”Molecular Pharmacology, vol. 55, 1999, pp. 377-385.
Labourier et al., “Poisoning of Topoisomerase I by an Antitumor Indolocarbazole Drug: Stabilization of Topoisomerase I-DNA Covalent Complexes and Specific Inhibition of the Protein Kinase Activity,”Cancer Research, vol. 59, 1999, pp. 52-55.
Okhubo et al., “Synthesis and Biological Activities of NB-506 Analogues: Effects of the Positions of two Hydroxyl Groups at the Indole Rings,”Bioorganic & Medicinal Chemistry Letters, vol. 9, 1999, pp. 3307-3312.
Okhubo et al., “Synthesis and Biological Activities of NB-506 Analogues Modified at the Glucose Group,”Bioorganic & Medicinal Chemistry Letters, vol. 10, 2000, pp. 419-422.
Anizon et al., “Syntheses and Biological Activities (Topoisomerase Inhibition and Antitumor and Antimicrobial Properties) of Rebeccamycin Analogues Bearing Modified Sugar Moieties and Substituted on the Imide Nitrogen with a Methyl Group”,J. Med. Chem., 1997, vol. 40, p. 3456-3465.
Bailly et al., “DNA Cleavage by Topoisomerase I in the Presence of Indolocarbazole Derivatives of Rebeccamycin”,Biochemsitry, 1997, vol. 36, p. 3917-3929.
Bailly et al., “Enhanced Binding to DNA and Topoisomerase I Inhibition by an Analog of the Antitumor Antibiotic Rebeccamycin Containing an Amino Sugar Residue”,Molecular Pharmacology, 1999, vol. 55, p. 377-385.
Labourier et al., “Poisoning of Topoisomerase I by an Antitumor Indolocarbazole Drug: Stabilization of Topoisomerase I-DNA Covalent Complexes and Specific Inhibition of the Protein Kinase Activity”,Cancer Research, Jan. 1, 1999, vol. 59, p. 52-55.
Okhubo et al., “Synthesis and Biological Activities of NB-506 Analogues Modified at the Glucose Group,”Bioorganic & Medicinal Chemistry Letters, 2000, vol. 10, pp. 419-422.
Glosssary Entry for Anomer, p. 1 of 1[online], [retrieved on Feb. 6. 2002]. Retrieved from Internet: <URL: http://www.vel.co.uk/TGN/glossary/entries/anomer.html>.
Molecular Recognition of Carbohydrates, pp. 1-6 [online], [retrieved on Feb. 6, 2002]. Retrieved from the Internet: <URL: http://www.nmr.chem.uu.n1/˜abonvin/ToT/damm/index.html>.
Monosaccharides Form Rings, pp. 1-2, Cabrillo College Chem 12B, Spring 1998 [online]. [retrieved on Apr. 1, 1999]. Retrieved from the Internet: <URL: http://www.cabrillo.cc.ca.us./divisions/becho/chem/hungar/exercise—3/html/12b33.html>.
Nomenclature of Carbohydrates (Recommendations 1996) 2-Carb-33, pp. 1-9 [online], [retrieved on Apr. 2, 1999]. Retrieved from the Internet: <URL: http://www.chem.qmw.ac.uk/lupac/2carb/33.html>.
Prevention of Anomer Separation, Monosaccharides and oligosaccarides, p. 1 [online], [retrieved on Apr. 1, 1999]. Retrieved from the Internet: <URL: http://www.hplc1.com/shodez/english/dc030202.htm>.
Sci.chem FAQ—Part 7 of 7 [online], [retrieved on Feb. 6, 2002]. Retrieved from the Internet: <URL: http:www.faqs.org/faqs/sci/chem-faq/part7/preamble.html>.
Stereo Oligomers and Polymers from Glycals: Oligomerisations, pp. 1-2 [online], [retrieved on Feb. 6, 2002]. Retrieved from the Internet: <URL: http://www.ch.ic.ac.uk./ectoc/echet96/papers/008/oligomers.html>.
Stereochemistry of Glycosyl Transfer: Interaction with “glucose” Active site of the Enzyme, pp. 1-2 [online], [retrieved on Feb. 6, 2002]. Retrieved from the Internet: <URL: http://www.netsci-journal.com/97v1/97005/005p30.htm>.

Affiliated with

Also associated with

Rating

Indolocarbazole anticancer agents and methods of using same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indolocarbazole anticancer agents and methods of using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolocarbazole anticancer agents and methods of using same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3705417